Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Corrigendum to "Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189" [Lung Cancer 155 (2021) 53-60].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 17, 2023
Real-world maintenance therapy and survival outcomes for pembrolizumab plus pemetrexed and platinum for non-small-cell lung cancer in USA.
Journal: Immunotherapy
Published: February 15, 2023
Pemetrexed and Platinum Plus Pembrolizumab in Patients With Metastatic Nonsquamous NSCLC by Tumor Burden at Baseline: A Post Hoc Efficacy Analysis of KEYNOTE-189.
Journal: JTO clinical and research reports
Published: April 27, 2022
Efficacy and Safety of Cetuximab Dosing (biweekly vs weekly) in Patients with KRAS Wild-type Metastatic Colorectal Cancer: A Meta-analysis.
Journal: The oncologist
Published: July 21, 2021
Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non-Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies.
Journal: Clinical lung cancer
Published: July 07, 2021
Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.
Journal: International journal of cancer
Published: January 08, 2021
Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 11, 2020
Pemetrexed maintenance with or without pembrolizumab in non-squamous non-small cell lung cancer: A cross-trial comparison of KEYNOTE-189 versus PARAMOUNT, PRONOUNCE, and JVBL.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 11, 2020
Response to Grannis FW. Current Controversies in Cardiothoracic Imaging: Overdiagnosis at Lung Cancer Screening-No So Bad After All-Counterpoint.
Journal: Journal of thoracic imaging
Published: March 07, 2020
Safety outcomes in advanced non-small-cell lung cancer patients treated with first-line platinum-based regimens in the United States.
Journal: Journal of thoracic disease
Published: January 07, 2020
A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 18, 2019
Earlier Diagnosis Not Self-Evidently Beneficial: Natural History of Subcentimeter Lung Cancers.
Journal: AJR. American journal of roentgenology
Published: May 24, 2019
Last Updated: 09/26/2026